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Hypertrophic Cardiomyopathy Versus Aortic Valvular Stenosis
Jeffrey B. Geske, MD, Michael W. Cullen, MD, Paul Sorajja, MD, Steve R. Ommen, MD,
Rick A. Nishimura, MD
Rochester, Minnesota
Objectives This study examined the relationship between peak-to-peak (common invasive measure-
ment), peak instantaneous (common Doppler measurement), and mean pressure gradients in pa-
tients with hypertrophic cardiomyopathy (HCM) and aortic stenosis (AS).
Background In patients with AS, the peak-to-peak gradient and peak instantaneous gradient are
discrepant, and the mean gradient best represents obstruction severity. The pathophysiology of out-
ﬂow obstruction differs in HCM, with the maximum gradient occurring in late systole, thus the opti-
mal method for quantifying gradient severity in HCM remains undeﬁned.
Methods Fifty patients with HCM and 50 patients with AS underwent gradient characterization at
cardiac catheterization (age 55  15 years vs. 72  9 years; 48% vs. 42% male, respectively). All
HCM patients were studied with high-ﬁdelity, micromanometer-tip catheters and transseptal mea-
surement of left ventricular inﬂow and central aortic pressures. In AS, simultaneous left ventricular
and central aortic pressures were recorded.
Results The peak instantaneous gradient was linearly correlated with peak-to-peak gradient in HCM
(R2  0.98, p  0.0001), with the relationship close to the line of identity. In AS, more scatter and
further deviation from the line of identity occurred when comparing the peak instantaneous gradi-
ent to the peak-to-peak gradient (R2  0.70, p  0.0001). Both peak-to-peak and peak instanta-
eous gradients were consistently higher than the mean gradient in HCM, with wide 95% conﬁ-
ence limits of agreement (26.7  46.5 mm Hg and 16.4  47.2 mm Hg, respectively).
onclusions In HCM, peak instantaneous and peak-to-peak gradient demonstrate excellent corre-
ation. Consequently, both peak instantaneous and peak-to-peak gradients can be used to clas-
ify obstruction severity in HCM. By contrast, the mean gradient should direct clinical manage-
ent in AS. (J Am Coll Cardiol Intv 2012;5:675–81) © 2012 by the American College of
ardiology Foundation
From the Divisions of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, College of Medicine, Rochester, Minnesota.
The authors have reported that they have no relationships relevant to the contents of this paper to disclose.Manuscript received November 10, 2011; revised manuscript received January 9, 2012, accepted January 20, 2012.
s
w
2
c
c
c
R
r
s
r
o
v
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 5 , N O . 6 , 2 0 1 2
J U N E 2 0 1 2 : 6 7 5 – 8 1
Geske et al.
LV Outflow Gradient in HCM and AS
676Hypertrophic cardiomyopathy (HCM) and aortic valve
stenosis (AS) are conditions characterized by left-sided
hemodynamic gradients. In HCM, myocardial hypertrophy
with abnormalities of the mitral valve apparatus leads to a
dynamic subvalvular left ventricular outflow tract (LVOT)
gradient in most patients (1–4). Determining the magnitude
of the LVOT gradient is paramount in patient management,
as it is innately tied to clinical symptoms and prognosis (5–14).
By contrast, the gradient of AS is fixed and develops secondary
to obstruction at the valvular level. The gradient in aortic
stenosis carries therapeutic and prognostic implications as well,
with severe aortic stenosis defined by an aortic valve mean
gradient exceeding 40 mm Hg (15–21).
Doppler echocardiography and cardiac catheterization are
the current methods for measuring the left ventricular
outflow gradient in both HCM and AS. Doppler echocar-
diography commonly reports a peak instantaneous gradient
utilizing the peak Doppler velocity with application of the
modified Bernoulli equation (22). By contrast, the peak-to-
peak gradient is the conventional method reported from cardiac
catheterization. In AS, the peak instantaneous gradient is always
higher than the peak-to-peak gradient and it is the mean gradient
that is recommended to be used
by both noninvasive and invasive
methods (15).
In contrast to AS, a generally
accepted standard measure of
the gradient in HCM does not
exist. Studies using Doppler echo-
cardiography have used the peak
instantaneous gradient, whereas
studies from the catheterization lab-
oratory use the peak-to-peak gradient. The American College of
Cardiology/American Heart Association (ACC/AHA) guide-
lines for the management of patients with HCM have
recommended using either parameter (23), but there has not
been a study comparing them directly. Thus, the purpose of
this study is to assess the relationship between peak-to-
peak, peak instantaneous, and mean gradient measurements
in populations of HCM, comparing these relationships to
the known discrepancies that occur in patients with AS.
Methods
HCM population. Between September 2005 and October
2009, 50 patients with HCM were evaluated at the Mayo
Clinic in Rochester, Minnesota, who met the following
criteria: 1) absence of aortic valvular disease; 2) cardiac cathe-
terization with high-fidelity, micromanometer-tip catheters
(Millar Instruments, Houston, Texas) for simultaneous
measurement of left ventricular (LV) and central aortic
pressures; 3) transseptal catheterization to avoid catheter
Abbreviations
and Acronyms
AS  aortic valve stenosis
HCM  hypertrophic
cardiomyopathy
LV  left ventricular
LVOT  left ventricular
outflow tractentrapment of the LV pressure (24); 4) sinus rhythm; and c5) informed consent. The diagnosis of HCM was based on
the presence of myocardial hypertrophy in the absence of
local or systemic etiologies (25,26) and verified via
2-dimensional transthoracic Doppler echocardiography.
Measurements of septal thickness and septal morphology
were performed as previously described (27).
AS population. During the same time frame as the HCM
tudy, 50 consecutive cases of patients with AS were selected
ho met the following criteria: 1) native aortic valve;
) absence of constrictive/restrictive physiology; 3) cardiac
atheterization with simultaneous measures of LV and
entral aortic pressures; 4) sinus rhythm; and 5) informed
onsent.
This study was approved by the Mayo Clinic Institutional
eview Board. All patients provided informed consent for
eview of their medical record in accordance with Minne-
ota law.
Invasive hemodynamic study. All invasive studies were per-
formed in a fasting state with conscious sedation. Cardio-
active medications were continued the day of the procedure.
Central aortic pressure was obtained from retrograde fem-
oral artery access with 6- or 7-F catheters. In patients with AS,
simultaneous LV and aortic pressures were recorded via retro-
grade crossing of the aortic valve or a transseptal antegrade
approach. In all patients with HCM, femoral venous access
was used to gain access to the right heart, and left heart
pressure measurements were performed via transseptal punc-
ture using 7- or 8-F catheters. High-fidelity, micromanometer-
tip catheters (Millar Instruments) were used in HCM
patients as previously described, with simultaneous assess-
ment of LV and aortic pressures (28).
All LV pressure measurements were taken in conjunction
with cineangiography to avoid catheter entrapment and
associated erroneous pressure readings (29). In patients
undergoing pharmacological evaluation or septal ablation,
baseline invasive data were acquired before septal alcohol
ablation or administration of cardiotropic medications.
Three methods to measure gradient (LVOT in the HCM
subset, transvalvular in the AS population) were used in all
patients. The largest spontaneous resting gradient in sinus
rhythm was evaluated for all patients, and all measurements
were made from the same beat. Peak-to-peak gradient was
the difference between the peak LV systolic pressure and the
peak central aortic pressure. Peak instantaneous gradient was
the maximum gradient present when simultaneous central
aortic pressure was subtracted from LV systolic pressure.
Mean gradient was the integral difference between LV
systolic pressure and central aortic pressure over the entire
systolic ejection period.
Data analysis. LVOT obstruction in HCM was defined as a
esting LVOT gradient of 30 mm Hg, with severe
bstruction defined as 50 mm Hg (10). Continuous
ariables were expressed as mean  SD. Correlation of
ontinuous variables was examined with simple linear regres-
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677sion analysis. Student t tests, Pearson chi-square analyses, and
Fisher exact tests were used as appropriate. Statistical signifi-
cance was set a priori at p  0.05.
Results
Baseline characteristics. Clinical characteristics of the study
population are listed in Table 1. The HCM population was
significantly younger than the patients with AS (55  15
years vs. 72  9 years, p  0.0001). Sex was evenly
istributed for both groups. Most patients in the HCM
roup (n  45, 90%) had moderately severe or severe
yspnea (New York Heart Association functional class III
Table 1. Baseline Characteristics
Variable HCM AS p Value
Age, yrs 55 15 72 9 0.0001
Male 24 (48) 21 (42) 0.40
Body mass index, kg/m2 33.6 7.8 30.2 5.4 0.01
NYHA functional class III or IV 45 (90) 19 (38) 0.0001
Pre-syncope or syncope 21 (42) 9 (18) 0.02
History of hypertension 32 (64) 38 (76) 0.30
LDL cholesterol, mg/dl 104 44 97 42 0.40
History of smoking 26 (52) 32 (64) 0.20
History of atrial ﬁbrillation 3 (6) 13 (26) 0.01
Permanent pacemaker 10 (20) 8 (16) 0.80
Internal cardioverter-deﬁbrillator 8 (16) 1 (2) 0.03
Family history of HCM 12 (24) — —
Family history of SCD 3 (6) — —
Prior septal reduction 3 (6) — —
Etiology of valvular disease
Calciﬁc — 38 (76) —
Rheumatic — 4 (8) —
Radiation-induced — 4 (8) —
Bicuspid — 4 (8) —
Echocardiographic ﬁndings
Left ventricular ejection fraction, % 69 8 57 17 0.0001
Mitral regurgitation, moderate or greater 11 (22) 4 (8) 0.09
Maximum ventricular wall thickness, mm 20.9 5.1 12.5 2.6 0.0001
Basal septal hypertrophy, % 33 (66) —
Aortic valve area by TVI, cm2 — 1.02 0.21 —
Corrected aortic valve MIG, mm Hg — 54 16 —
Mean AS gradient, mm Hg — 33 10 —
Medications
Beta-receptor antagonist 42 (84) 30 (60) 0.01
Calcium-channel blocker 24 (48) 5 (10) 0.0001
ACE inhibitor or ARB 14 (28) 28 (56) 0.008
Disopyramide 6 (12) 0 (0) 0.03
Amiodarone 1 (2) 4 (8) 0.40
Values are mean SD or n (%).
ACE  angiotensin-converting enzyme; ARB  angiotensin-receptor blocker; AS  aortic
valvular stenosis; HCM  hypertrophic cardiomyopathy; LDL  low-density lipoprotein; MIG 
maximal instantaneous gradient; NYHA  New York Heart Association; SCD  sudden cardiac
death; TVI tissue velocity imaging.r IV). Significantly fewer were severely symptomatic in theS population (n  19, 38%, p  0.0001). Basal septal
hypertrophy was noted in most HCM patients (n  33,
66%), with the remainder demonstrating concentric hyper-
trophy or hypertrophy isolated to the distal septum, apex, or
free wall. The most common etiology of valvular stenosis
was calcific degenerative (n  38, 76%). The groups were
not different with regard to history of hypertension, mea-
sured low-density lipoprotein cholesterol, smoking history,
or history of permanent pacemaker implantation.
Hemodynamic assessment. Hemodynamic variables at car-
diac catheterization are outlined in Table 2. Patients with
AS were significantly more hypertensive than patients with
HCM at the time of cardiac catheterization, with similar
diastolic blood pressure and heart rates. Representative
hemodynamic tracings are shown for patients with HCM
and AS (Fig. 1).
Quantitation of gradient. Peak instantaneous LVOT gradi-
nt showed a strong linear correlation with peak-to-peak
radient in patients with HCM (y  0.99x  10.6, R2 
0.98, p  0.0001) (Fig. 2A), closely paralleling the line of
identity. Peak instantaneous aortic valve gradient was lin-
early correlated with peak-to-peak gradient in patients with
AS. More scatter and further deviation from the line of
identity occurred in patients with AS (y  1.05x  18.8,
R2  0.70, p  0.0001) (Fig. 2B), albeit in the setting of a
maller gradient range.
Peak-to-peak gradient correlated with mean gradient
ithin the HCM population (R2  0.98, p  0.0001), but
eviated from the line of identity (Fig. 3). Similarly, the
eak instantaneous gradient correlated with the mean gra-
ient in HCM patients (R2  0.98, p  0.0001) but
eviated from the line of identity (Fig. 4). When compared
ith the mean LVOT gradient measures in HCM, both
eak-to-peak and peak instantaneous values were consis-
ently higher, with wide 95% confidence intervals of agree-
ent (26.7  46.5 mm Hg and 16.4  47.2 mm Hg,
espectively).
Table 2. Hemodynamic Variables at Cardiac Catheterization
Variable HCM AS p Value
Aortic systolic blood pressure, mm Hg 117.5 19.6 141.3 30.0 0.0001
Aortic diastolic blood pressure, mm Hg 71.0 11.4 66.4 11.4 0.05
Heart rate, beats/min 71 13 71 13 0.80
Double product, mm Hg/min 8,387 2,393 10,068 2,742 0.002
Peak-to-peak gradient, mm Hg 51.8 51.9 27.2 12.2 0.002
Peak instantaneous gradient, mm Hg 62.1 52.1 47.5 15.5 0.06
Mean gradient, mm Hg 35.4 29.6 30.0 10.2 0.20
Values are mean SD.Abbreviations as in Table 1.
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678Discussion
This paper demonstrates that in patients with HCM, the
peak-to-peak gradient closely correlates with the peak
instantaneous gradient. Assessment of this relationship
demonstrates a very close fit to the line of identity. The
correlation of peak-to-peak gradient and peak instantaneous
gradient was less robust for patients with AS, as has been
previously described. Given the strong linear relationship
between these measures in HCM, as well as the physiolog-
ical mechanism of the gradient, Doppler-derived measure-
ments reflecting the peak instantaneous gradient and di-
rectly measured peak-to-peak gradients at catheterization
can be used interchangeably in HCM.
The LVOT gradient in HCM occurs via a unique
mechanism. During ventricular systole, blood flow acceler-
ates across the septum, leading to a drag effect on the
displaced mitral valve apparatus, which “pushes” the leaflets
into the LVOT (30–34). Dynamic obstruction occurs
primarily in late systole as systolic anterior motion of the
mitral valve occurs. Effects on gradient have been demon-
strated from fluctuations in volume status, autonomic ner-
vous activity, diurnal variation, pharmacotherapy, exercise,
and physical position during assessment (4,34–37), and
variability in the magnitude of gradient has been demon-
strated over the course of minutes (38). Quantification of
LVOT gradient remains central to the management algo-
rithm of patients with HCM. The presence of severe
obstruction portends increased cardiac morbidity and mor-
tality (9–11,13). Medical therapy that prevents exercise-
induced increases in gradient is the initial treatment in
Figure 1. Gradient Measurement at Cardiac Catheterization
Continuous high-ﬁdelity left ventricular (LV) and aortic (Ao) hemodynamic
tracings were used for evaluation of patients with aortic stenosis (left) and
hypertrophic cardiomyopathy (right). Peak instantaneous and peak-to-peak
gradient measures are shown.patients with documented gradients. If pharmacologicaltherapy is unsuccessful in relieving severe obstruction, septal
reduction therapy is indicated (5–8,12). The ACC/AHA
guidelines for the management of patients with HCM have
recommended proceeding with septal reduction therapy only if
there is a resting or provoked gradient 50 mm Hg (23). It is
thus important to develop a standardized approach for report-
ing the magnitude of the gradient in HCM.
Echocardiographic assessment of valvular gradient uses
the modified Bernoulli equation, pressure  4(velocity)2,
hich is usually applied to the peak instantaneous velocity
22). Mean gradient can be determined via integration of
he continuous-wave Doppler signal. By contrast, measure-
ent at invasive catheterization conventionally reports the
ifference between peak left ventricular and peak aortic
ressure tracings. Mean gradient can be calculated as the
ntegrated difference between these waveforms.
In AS, the peak instantaneous gradient often exceeds the
eak-to-peak gradient (39), and thus, the 2 measurements
hould not be used synonymously. By contrast, peak instan-
aneous gradient and peak-to-peak gradient were found to
Figure 2. Peak-to-Peak Versus Peak Instantaneous Gradient
Scatterplots of peak-to-peak versus peak instantaneous gradient measures
for hypertrophic cardiomyopathy (HCM) (A) and aortic valve stenosis (AS)
(B) demonstrate linear correlations.
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679be equivalent in HCM. The reason for this incongruity
becomes apparent upon inspection of the pressure waveform
morphologies (Fig. 1). In AS, a constant degree of obstruc-
tion is present from the time the aortic valve opens until the
time it closes. As such, the mean gradient throughout the
systolic ejection period is indicative of the severity of
stenosis. By contrast, the gradient in HCM is dynamic.
Obstruction is minimal in early systole, rapidly increases
during the systolic ejection period, and peaks in late systole.
Due to late peaking obstruction, the aortic contour has a
“spike and dome” pattern, with aortic pressure changing
little during mid and late systole. Thus, the true severity of
the obstruction is best measured in late systole.
Prior studies have reported on the maximum instanta-
neous gradient when using Doppler echocardiography and
the peak-to-peak gradient using catheterization for both
prognosis as well as criteria for treatment. Resting obstruc-
tion is present when the gradient exceeds 30 mm Hg, which
does portend a poorer prognosis (10). Severe obstruction
amenable to septal reduction therapy requires a gradient
50 mm Hg. However, there has not been a systematic
study that correlates the peak instantaneous and peak-to-
peak gradients. Our findings support the recent ACC/AHA
guideline recommendations that either Doppler-derived
peak instantaneous gradient or peak-to-peak gradient at
cardiac catheterization can be used to accurately quantitate
LVOT gradient in patients with HCM (23).
Study limitations. Significant differences exist between the
aseline characteristics of the included AS and HCM
atient populations. These findings are not unexpected,
iven the known demographic differences between these
isease processes. The intent of this study was not that of a
ase control, but rather to characterize hemodynamic assess-
Figure 3. Peak-to-Peak Versus Mean Gradient
Scatterplots of peak-to-peak versus mean gradient measures for patients
with hypertrophic cardiomyopathy.ent of the gradient throughout these populations. Patientsith HCM were significantly more symptomatic than those
ith AS, which prompted invasive assessment in this
atient group. However, it is unlikely that functional class
ignificantly altered quantitative assessment of gradient.
Diligent selection of high-quality measurements for gra-
ient characterization was performed. All patients with AS
ad simultaneous measures of LV and aortic pressures, and
ll patients with HCM had transseptal studies with high-
delity micromanometer-tipped catheters. Fastidious care was
aken to avoid catheter entrapment, but this is a potential
onfounder in the setting of small, hyperdynamic LV
avities. We did not perform Doppler echocardiography and
atheterization simultaneously; however, previous studies
ave shown that Doppler velocities can be accurately con-
erted to pressure gradients across the LVOT in patients
ith HCM (40).
onclusions
Peak instantaneous gradient was strongly linearly correlated
with peak-to-peak gradient in HCM, paralleling the line of
identity. This relationship was less robust in AS, with more
scatter and further deviation from the line of identity noted.
Given strong linear relationships between these 2 gradient
measures as well as the pathophysiology of obstruction,
Doppler-derived gradient (peak instantaneous) and peak-
to-peak gradient obtained at cardiac catheterization should
be the standard methodology to report the severity of
obstruction in patients with HCM. This is opposed to
patients with aortic stenosis, where the mean gradient is the
standard for both Doppler echocardiography and cardiac
catheterization.
Figure 4. Peak Instantaneous Versus Mean Gradient
Scatterplots of peak instantaneous versus mean gradient measures for
patients with hypertrophic cardiomyopathy.
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